首页> 外文OA文献 >Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

【2h】

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

机译：Ki67在围手术期内分泌治疗后的长期结果和预后价值在绝经后患者患有激素敏感的早期乳腺癌（诗意）：开放标签，多期，并联组，随机，第3阶段试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ian Smith; John Robertson; Lucy Kilburn; Maggie Wilcox; Abigail Evans; Chris Holcombe; Kieran Horgan; Cliona Kirwan; Elizabeth Mallon; Mark Sibbering; Anthony Skene; Raghavan Vidya; Maggie Cheang; Jane Banerji; James Morden; Kally Sidhu; Andrew Dodson; Judith M Bliss; Mitch Dowsett;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial [J] . Prat Aleix, Saura Cristina, Pascual Tomas, The lancet oncology . 2020,第1期

机译：Ribociclib加仑唑唑与化疗进行后代妇女患有激素受体阳性，Her2阴性，腔乳腺癌（Coralleen）：开放标签，多期中心，随机，第2期试验
2. Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial [J] . Colleoni Marco, Luo Weixiu, Karlsson Per, The lancet oncology . 2018,第1期

机译：延长佐剂间歇性Letrozole与乳腺癌后期妇女的连续letrozole（鞋底）：多期，开放标签，随机，第3期试验
3. Adjuvant tamoxifen and exemestane in women with postmenopausal early breast cancer (TEAM): 10-year follow-up of a multicentre, open-label, randomised, phase 3 trial [J] . Derks Marloes G. M., Blok Erik J., Seynaeve Caroline, The lancet oncology . 2017,第9期

机译：辅助Tamoxifen和妇女患有绝经后早期乳腺癌（团队）的妇女：10年的多中心随访，开放标签，随机，第3阶段试验
4. Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase Ⅱ clinical trial [C] . Gabriela L. Ferrel, Feifan Zhou, Xiaosong Li, Biophotonics and immune responses IX . 2014

机译：Ⅱ期临床试验中激光免疫疗法对晚期转移性乳腺癌患者的影响
5. Sexuality and gynaecological cancer: A randomised control trial to evaluate the effectiveness of a group psychoeducational intervention in improving the sexual health of women with gynaecological cancer treated with radiotherapy [D] . Jeffries, Sherryl Anne 2003

机译：性与妇科癌症：一项随机对照试验，旨在评估团体心理教育干预措施对经放射治疗的妇科癌症妇女改善性健康的有效性
6. Accelerated versus standard epirubicin followed by cyclophosphamide methotrexate and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre phase 3 open-label randomised controlled trial [O] . David Cameron, James P Morden, Peter Canney, -1

机译：英国TACT2随机试验（CRUK / 05/19）：加速与标准表柔比星联合环磷酰胺甲氨蝶呤氟尿嘧啶或卡培他滨作为乳腺癌的辅助治疗：一项多中心3期开放标签随机对照试验
7. Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial [O] . Albain Kathy S, Barlow William E, Ravdin Peter M, 2010

机译：三苯氧胺对绝经后内分泌反应性，淋巴结阳性的乳腺癌患者的辅助化疗和时机：一项3期，开放标签，随机对照试验

Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial

著录项

相似文献

相关主题

期刊订阅